Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 68.91
+2.15 (3.22%)
At close: Oct 16, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 30.29 billion as of October 16, 2026. It is the 18,054th most valuable company in the world and the 1,066th biggest in India. Its market cap has increased by 93.30% in one year.
Market Cap
30.29B
Enterprise Value
30.28B
Revenue
748.59M
Global Rank
Country Rank
#1,066 India
PE Ratio
85.25
ChartMarket Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 30.29B, an increase of 65,526.21%. That is a compound annual growth rate of 55.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 30.29B | 16.76% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 57.19B |
| Evonile Pharma | 47.83B |
| Gufic Biosciences | 41.10B |
| Unichem Laboratories | 36.62B |
| Kwality Pharmaceuticals | 34.41B |
| Hikal | 26.66B |
| Fredun Pharmaceuticals | 24.01B |
| Venus Remedies | 20.91B |